World|March 10, 2026

Novo Nordisk is warned by the FDA for failing to report side effects

It's the third time in recent weeks that the FDA has admonished Novo Nordisk for different practices.

Editorial Staff·1 min read

Summary

Summary pending editorial review.

Key Facts

Key facts pending editorial review.

Sources

STAT: https://www.statnews.com/pharmalot/2026/03/10/novo-failed-report-side-effects-fda-wegovy-ozempic/?utm_campaign=rss

Updates

Update at 13:29 UTC on 2026-03-11

STAT reported Recent developments highlight the FDA's warning to Novo Nordisk and Lilly's strategic investments in China.

Sources: STAT